Alpha Tau Medical Ltd. (NASDAQ:DRTS – Get Rating)’s stock price traded down 3.3% during trading on Friday . The stock traded as low as $11.75 and last traded at $12.00. 458 shares changed hands during trading, a decline of 100% from the average session volume of 164,250 shares. The stock had previously closed at $12.41.
Several equities research analysts recently commented on the company. Piper Sandler assumed coverage on Alpha Tau Medical in a report on Friday, April 8th. They set an “overweight” rating and a $19.00 target price on the stock. Cantor Fitzgerald assumed coverage on Alpha Tau Medical in a report on Thursday, April 14th. They set an “overweight” rating and a $20.00 target price on the stock. Finally, Citigroup assumed coverage on Alpha Tau Medical in a report on Monday, April 4th. They set a “buy” rating and a $21.00 target price on the stock.
The business has a 50-day moving average of $8.28.
A number of institutional investors have recently bought and sold shares of DRTS. Clear Street LLC acquired a new position in Alpha Tau Medical in the first quarter worth approximately $30,000. Penserra Capital Management LLC purchased a new position in Alpha Tau Medical during the 1st quarter worth approximately $40,000. Finally, Ergoteles LLC purchased a new position in Alpha Tau Medical during the 1st quarter worth approximately $146,000. Hedge funds and other institutional investors own 81.91% of the company’s stock.
Alpha Tau Medical Company Profile (NASDAQ:DRTS)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
- Get a free copy of the StockNews.com research report on Alpha Tau Medical (DRTS)
- eBay’s Long Term Fundamentals Are Intact If You Can Stomach Short Term Volatility
- Honda’s Stock Continues To Fly Under The Radar
- Vuzix Stock Stays Optimistic
- Palo Alto Networks: Pioneering AI in Cybersecurity
- Dividend Stocks and Your Roth IRA
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.